Literature DB >> 27371803

Risk-taking behavior and impulsivity among HCV-infected patients.

Adriana Dantas-Duarte1, Mychelle Morais-de-Jesus1, Ana Paula Nunes1, Karine Miranda-Pettersen1, Lucas Araújo-de-Freitas1, Liana R Netto1, Carlos Teles Santos2, Liana Codes3, Lucas C Quarantini4.   

Abstract

The association between risk behaviors and hepatitis C virus (HCV) has been extensively studied. It is also proved that impulsivity is associated with risk behaviors. However, there is a lack of studies investigating the association between HCV and impulsivity, a characteristic that can contribute directly to these risk behaviors. This study aimed to investigate HCV-infected individuals' impulsivity and whether this feature mediates risk behavior. Adult patients with liver diseases (n=269) were divided into two groups: viral group (n=157) - patients with HCV and nonviral group (n=112). Risk behaviors were evaluated by a sociodemographic questionnaire. Impulsivity was assessed through Barratt Impulsiveness Scale - BIS-11. Psychiatric comorbidities were investigated by the Mini International Neuropsychiatric Interview 5.0.0. The viral group patients had higher impulsivity than the nonviral group in all domains: attentional impulsivity, motor impulsivity, and nonplanning. Risk behaviors were also shown to be associated with impulsivity levels. Our results suggest that HCV-infected patients are more impulsive than individuals with other liver diseases, even when analyses are controlled for the presence of comorbid mental disorders. In addition, at-risk behavior was significantly mediated by impulsivity.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  BIS-11; HCV; Hepatitis C; Impulsivity

Mesh:

Year:  2016        PMID: 27371803     DOI: 10.1016/j.psychres.2016.04.114

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Functional MRI and delay discounting in patients infected with hepatitis C.

Authors:  Holly McCready; Milky Kohno; Michael Kolessar; Laura Dennis; Daniel Kriz; Hannah Luber; Renee Anderson; Michael Chang; Anna Sasaki; Kenneth Flora; Arthur Vandenbark; Suzanne H Mitchell; Jennifer M Loftis; William F Hoffman; Marilyn Huckans
Journal:  J Neurovirol       Date:  2018-10-08       Impact factor: 2.643

2.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study.

Authors:  Rachel M Arends; Erni J Nelwan; Ratna Soediro; Reinout van Crevel; Bachti Alisjahbana; Herdiman T Pohan; A Katinka L von Borries; Aart H Schene; André J A M van der Ven; Arnt F A Schellekens
Journal:  PLoS One       Date:  2019-02-15       Impact factor: 3.240

3.  Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014.

Authors:  Tint-Swe Latt; Ko-Ko Zaw; Ko Ko; Moh-Moh Hlaing; Mya Ohnmar; Ei-Sandar Oo; Kyaw-Myint-Myat Thein; Motoyuki Yuasa
Journal:  Diabetes Metab Syndr Obes       Date:  2019-03-04       Impact factor: 3.168

4.  Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.

Authors:  Ashwin Rao; Jody A Rule; Giuliana Cerro-Chiang; Richard T Stravitz; Brendan M McGuire; Goo Lee; Robert J Fontana; William M Lee
Journal:  Dig Dis Sci       Date:  2022-05-11       Impact factor: 3.487

5.  The Prevalence of Psychotic Symptoms, Violent Ideation, and Disruptive Behavior in a Population With SARS-CoV-2 Infection: Preliminary Study.

Authors:  Sumra Bari; Nicole L Vike; Khrystyna Stetsiv; Sean Woodward; Shamal Lalvani; Leandros Stefanopoulos; Byoung Woo Kim; Nicos Maglaveras; Hans C Breiter; Aggelos K Katsaggelos
Journal:  JMIR Form Res       Date:  2022-08-16

6.  Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study.

Authors:  Ricardo Henrique-Araújo; Lucas C Quarantini; André C Caribé; Felipe C Argolo; Ana Paula Jesus-Nunes; Mychelle Morais-de-Jesus; Adriana Dantas-Duarte; Tayne Miranda Moreira; Irismar Reis de Oliveira
Journal:  Braz J Infect Dis       Date:  2019-07-22       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.